Mirena® intrauterine system in the treatment of menstrual disorders: A survey of UK patients' experience, acceptability and satisfaction

Journal of Obstetrics and Gynaecology

Volumn 28, Issue 7, 2008, Pages 728-731

  Robinson, R ^a,b   China, S ^a   Bunkheila, A ^a   Powell, M ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Continuation rate; Menstrual disorders; Mirena intrauterine system; Patient satisfaction

Indexed keywords

LEVONORGESTREL;

ACNE; ADULT; AGED; ARTICLE; BLEEDING; BLOATING; BREAST TENDERNESS; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; HAIR DISEASE; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; PATIENT SATISFACTION; PELVIS PAIN SYNDROME; PERSONAL EXPERIENCE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SIDE EFFECT; SPOTTING; TREATMENT DURATION; TREATMENT OUTCOME; UNITED KINGDOM; VAGINA BLEEDING; WEIGHT GAIN; INTRAUTERINE CONTRACEPTIVE DEVICE; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GREAT BRITAIN; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENSTRUATION DISTURBANCES; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 57449102120     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610802462605     Document Type: Article

References (11)

1. ACOG. 2006. Committee Opinion No. 337: Noncontraceptive uses for the Levonorgestrel Intrauterine System. Obstetrics and Gynacology 107:1479.
2. Anonymous. 2001. Levonorgestrel intrauterine system for menorrhagia. Drug and Therapeutics Bulletin 39:85-87.
3. Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M. 2000. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nationwide study of 17,360 users. British Journal of Obstetrics and Gynaecology 107:335-339.
4. Baldaszti E, Wimmer-Puchinger B, Loschke K. 2003. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 67:87-91.
5. Chi IC, Farr G. 1994. The non-contraceptive effects of the levonorgestrel-releasing intrauterine device. Advances in Contraception 10:271-285.
6. Chrisman C, Ribeiro P, Dalton VK. 2007. The Levonorgestrel-releasing Intrauterine System: An updated review of contraceptive and noncontraceptive uses. Clinical Obstetrics and Gynaecology 50:886-897.
7. Diaz J, Bahamondes L, Monteiro I, Petta C, Hildalgo MM, Arce XE. 2000. Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil. Contraception 62:59-61.
8. Lethaby AE, Cooke I, Rees M. 2005. Progesterone/progestogen releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 4:CD002126.
9. Mukherjee K, Jones K. 2005. The treatment of dysfunctional uterine bleeding with the Mirena IUS: a survival analysis. Gynaecological Surgery 2:251-254.
10. Sivin I, Mahgoub SE, McCarthy T. 1990. Long-term contraception with the levonorgestrel 20 μg/day and the copper T380Ag intrauterine devices: a five-year randomised study. Contraception 42:361-378.
11. Sivin I, Stern J, Coutinho E, Mattos CE, el Mahgoub S, Diaz S et al. 1991. Prolonged intrauterine contraception: a seven year randomized study of levonorgestrel 20mcg/day and the copper T 380Ag IUDs. Contraception 44:473-480.